How to Time LAI Initiation in Newly Diagnosed Schizophrenia
How should clinicians time long-acting injectable antipsychotic initiation after a new schizophrenia diagnosis to minimize psychiatric hospitalization burden?
Patients with newly diagnosed schizophrenia often relapse or require rehospitalization when antipsychotic adherence is poor. This study addresses a practical timing question for clinicians considering LAI treatment during the early course of illness, especially when trying to reduce future psychiatric hospitalization days.
-
Frame the decision around years since diagnosis
Estimate how long it has been since schizophrenia was diagnosed and place the patient into a clinically relevant interval: within 1 year, 1 to 2 years, 2 to 3 years, 3 to 4 years, 4 to 5 years, or more than 5 years. The study analyzed outcomes using these 1-year intervals because they align with the first 5 years as a critical period and with annual maintenance-treatment reassessment.
-
Discuss LAI treatment within the first year when feasible
In this cohort of patients who went on to receive continuous LAI treatment, initiation within 1 year was associated with fewer psychiatric hospitalization days than initiation after 5 years. The clearest full-cohort difference was that patients started more than 5 years after diagnosis had a significantly higher hospitalization-day ratio than those started within 1 year.
-
Avoid prolonged delay beyond 5 years if hospitalization reduction is the goal
If LAI treatment is being considered but has been deferred for years, do not assume timing no longer matters. Initiation more than 5 years after diagnosis was associated with higher hospitalization-day ratios, and within that more-than-5-year group, each additional delay was linearly associated with greater hospitalization burden.
-
Prioritize earlier LAI discussion in patients with greater illness severity
Among patients who experienced psychiatric hospitalization during LAI treatment, the association favoring earlier initiation was stronger. Compared with starting within 1 year, starting at 1 to 2 years, 3 to 4 years, and more than 5 years was associated with significantly higher hospitalization-day ratios in this subgroup.
-
Use delayed initiation data to inform expectations, not to justify waiting
Later LAI initiation was associated with lower discontinuation risk, with significantly lower hazards emerging at 2 to 3 years, 3 to 4 years, 4 to 5 years, and more than 5 years compared with initiation within 1 year. When counseling patients, balance this persistence finding against the hospitalization finding that earlier initiation was associated with fewer hospitalization days.
Clinical Considerations
- The findings are associative and come from nationwide administrative claims data rather than a randomized treatment protocol.
- The cohort was restricted to patients who achieved continuous LAI treatment, so results may not generalize to all patients offered an LAI.
- Important clinical factors such as symptom severity, functional status, and patient insight were unavailable and may have influenced both LAI timing and outcomes.
- Some patients classified as incident schizophrenia may have had prior psychotic episodes before study registration, so the cohort represents newly diagnosed rather than strictly first-episode schizophrenia.
Bottom Line
If reducing psychiatric hospitalization burden is the main goal, discuss and consider LAI initiation early after schizophrenia diagnosis rather than deferring it for years, especially not beyond 5 years.
